Exploratory study investigating ocular blood flow in colorectal cancer patients before and after treatment with anti-angiogenic therapy
Latest Information Update: 21 Sep 2022
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Biomarker; Pharmacodynamics; Therapeutic Use
- 21 Sep 2022 Status changed from recruiting to completed.
- 09 Jul 2014 New trial record